BioAtla, Inc. (BCAB) Reports In-Line Q3 EPS
BioAtla, Inc. (NASDAQ: BCAB) reported Q3 EPS of ($0.27), in-line with the analyst estimate of ($0.27).
For earnings history and earnings-related data on BioAtla, Inc. (BCAB) click here.
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share